Advantagene
Advantagene, a biotechnology company, develops and commercializes cancer immunotherapy drugs. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€51—76m (Dealroom.co estimates Sep 2016.)
Needham Massachusetts (HQ)
Authorizing premium user...